Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intellectual Disability | 7 | 2024 | 1055 | 0.570 |
Why?
|
| Outpatients | 2 | 2022 | 256 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2024 | 502 | 0.310 |
Why?
|
| Microcephaly | 2 | 2023 | 330 | 0.280 |
Why?
|
| Histones | 2 | 2024 | 542 | 0.270 |
Why?
|
| Movement Disorders | 2 | 2023 | 222 | 0.270 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2018 | 90 | 0.250 |
Why?
|
| Siblings | 2 | 2017 | 186 | 0.250 |
Why?
|
| Mutation | 5 | 2020 | 5900 | 0.240 |
Why?
|
| Developmental Disabilities | 3 | 2020 | 715 | 0.230 |
Why?
|
| Abnormalities, Multiple | 3 | 2020 | 960 | 0.220 |
Why?
|
| DiGeorge Syndrome | 1 | 2014 | 80 | 0.220 |
Why?
|
| Brachydactyly | 1 | 2022 | 10 | 0.210 |
Why?
|
| Parent-Child Relations | 1 | 2014 | 247 | 0.200 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 13 | 0.200 |
Why?
|
| Genetic Testing | 3 | 2024 | 1012 | 0.200 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 136 | 0.200 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 343 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 70 | 0.190 |
Why?
|
| Dwarfism | 1 | 2022 | 97 | 0.190 |
Why?
|
| Phenotype | 4 | 2024 | 4268 | 0.180 |
Why?
|
| Mosaicism | 1 | 2022 | 239 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2018 | 150 | 0.170 |
Why?
|
| Medicaid | 1 | 2022 | 240 | 0.170 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2020 | 15 | 0.170 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 30 | 0.160 |
Why?
|
| Carrier Proteins | 3 | 2020 | 1033 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 850 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 398 | 0.150 |
Why?
|
| Nephrosis | 1 | 2017 | 4 | 0.140 |
Why?
|
| Parents | 1 | 2014 | 1026 | 0.140 |
Why?
|
| Actins | 1 | 2019 | 345 | 0.140 |
Why?
|
| Sequence Deletion | 2 | 2016 | 528 | 0.140 |
Why?
|
| Arginine | 1 | 2019 | 334 | 0.140 |
Why?
|
| Pedigree | 5 | 2020 | 1607 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 55 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2018 | 229 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 116 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 36 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 2017 | 147 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 210 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 780 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 100 | 0.130 |
Why?
|
| Failure to Thrive | 1 | 2016 | 90 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 228 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 246 | 0.120 |
Why?
|
| Adolescent | 10 | 2024 | 19409 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 3175 | 0.120 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 107 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 134 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 124 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2017 | 300 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 161 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 257 | 0.110 |
Why?
|
| Chromatin | 1 | 2016 | 578 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 559 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 963 | 0.100 |
Why?
|
| Exome | 3 | 2024 | 1034 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1537 | 0.100 |
Why?
|
| Germ Cells | 2 | 2024 | 196 | 0.100 |
Why?
|
| Epilepsy | 1 | 2020 | 874 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2024 | 14114 | 0.100 |
Why?
|
| Humans | 19 | 2024 | 125287 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 2059 | 0.090 |
Why?
|
| Child | 9 | 2024 | 24571 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1283 | 0.090 |
Why?
|
| Male | 12 | 2024 | 61544 | 0.080 |
Why?
|
| Texas | 3 | 2024 | 3582 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 2799 | 0.080 |
Why?
|
| Female | 12 | 2024 | 66802 | 0.080 |
Why?
|
| Models, Molecular | 3 | 2017 | 1084 | 0.080 |
Why?
|
| Genome, Human | 1 | 2016 | 1293 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 560 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 809 | 0.060 |
Why?
|
| Young Adult | 4 | 2024 | 9058 | 0.060 |
Why?
|
| Sibling Relations | 1 | 2014 | 12 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2018 | 359 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2017 | 836 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 88 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 42 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 79 | 0.050 |
Why?
|
| Karyotyping | 1 | 2022 | 323 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 449 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 249 | 0.050 |
Why?
|
| Infant | 3 | 2024 | 12570 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 772 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2023 | 738 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 358 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 436 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2020 | 8253 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 101 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 620 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2018 | 32 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 152 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 602 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 244 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 65 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 29579 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 547 | 0.040 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2017 | 11 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 355 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 381 | 0.030 |
Why?
|
| Dynamins | 1 | 2017 | 38 | 0.030 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 44 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2017 | 64 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 352 | 0.030 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 48 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2017 | 72 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 125 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
| Point Mutation | 1 | 2018 | 351 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 80 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 73 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 116 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 186 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 168 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 75 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 200 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 1520 | 0.030 |
Why?
|
| Mice | 3 | 2017 | 17736 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 262 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 312 | 0.030 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 187 | 0.030 |
Why?
|
| Face | 1 | 2016 | 179 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 888 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 669 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 380 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 85 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 254 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 3741 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 486 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 556 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 573 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 587 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1122 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 854 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16345 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 793 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 2569 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 1617 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 871 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 34299 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 879 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2250 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 886 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1816 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3751 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4835 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4418 | 0.020 |
Why?
|
| United States | 1 | 2022 | 10875 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4405 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19700 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 3010 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 26788 | 0.010 |
Why?
|